Nomura Holdings Inc. acquired a new position in shares of HCA Healthcare Inc (NYSE:HCA) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 218,802 shares of the company’s stock, valued at approximately $29,442,000. Nomura Holdings Inc. owned about 0.06% of HCA Healthcare at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently modified their holdings of HCA. Rational Advisors LLC raised its stake in HCA Healthcare by 5,118.2% in the first quarter. Rational Advisors LLC now owns 574 shares of the company’s stock valued at $75,000 after buying an additional 563 shares during the last quarter. Magellan Asset Management Ltd raised its stake in HCA Healthcare by 21.0% in the second quarter. Magellan Asset Management Ltd now owns 15,621,068 shares of the company’s stock valued at $2,111,500,000 after buying an additional 2,712,130 shares during the last quarter. Amundi Pioneer Asset Management Inc. raised its stake in HCA Healthcare by 2.3% in the first quarter. Amundi Pioneer Asset Management Inc. now owns 1,290,505 shares of the company’s stock valued at $168,257,000 after buying an additional 28,925 shares during the last quarter. Ballentine Partners LLC purchased a new stake in HCA Healthcare in the first quarter valued at about $209,000. Finally, Burney Co. increased its holdings in shares of HCA Healthcare by 2.2% in the first quarter. Burney Co. now owns 79,903 shares of the company’s stock valued at $10,418,000 after purchasing an additional 1,751 shares during the period. Hedge funds and other institutional investors own 70.19% of the company’s stock.
HCA Healthcare stock traded down $2.11 during midday trading on Friday, hitting $124.71. 1,103,912 shares of the company were exchanged, compared to its average volume of 1,312,823. The firm has a market capitalization of $43.25 billion, a PE ratio of 12.76, a price-to-earnings-growth ratio of 1.07 and a beta of 0.87. HCA Healthcare Inc has a fifty-two week low of $110.31 and a fifty-two week high of $147.42. The business has a fifty day simple moving average of $124.80 and a two-hundred day simple moving average of $128.73.
The business also recently announced a quarterly dividend, which will be paid on Monday, September 30th. Investors of record on Tuesday, September 3rd will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a yield of 1.28%. The ex-dividend date of this dividend is Friday, August 30th. HCA Healthcare’s dividend payout ratio (DPR) is 16.38%.
In related news, SVP Kathleen M. Whalen sold 977 shares of the firm’s stock in a transaction dated Tuesday, August 13th. The stock was sold at an average price of $127.56, for a total transaction of $124,626.12. Following the sale, the senior vice president now directly owns 11,484 shares of the company’s stock, valued at $1,464,899.04. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, major shareholder Patricia F. Elcan acquired 250 shares of the company’s stock in a transaction on Tuesday, August 6th. The stock was acquired at an average cost of $124.10 per share, for a total transaction of $31,025.00. The disclosure for this purchase can be found here. 2.70% of the stock is owned by company insiders.
A number of brokerages have recently weighed in on HCA. Mizuho set a $153.00 price objective on HCA Healthcare and gave the company a “buy” rating in a report on Wednesday, July 31st. Zacks Investment Research lowered HCA Healthcare from a “buy” rating to a “hold” rating and set a $130.00 price objective on the stock. in a report on Monday, May 27th. ValuEngine lowered HCA Healthcare from a “hold” rating to a “sell” rating in a report on Tuesday. UBS Group increased their price objective on HCA Healthcare from $172.00 to $181.00 and gave the company a “buy” rating in a report on Monday, June 24th. Finally, Goldman Sachs Group raised HCA Healthcare from a “neutral” rating to a “buy” rating and increased their price objective for the company from $147.00 to $160.00 in a report on Wednesday, July 10th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and fifteen have assigned a buy rating to the company. The company presently has an average rating of “Buy” and a consensus price target of $155.29.
HCA Healthcare Profile
HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.
Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).
Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.